IGC Pharma (IGC) Selling, General & Administrative (2010 - 2025)
Powered by 
Analysis
IGC Pharma (IGC) Selling, General & Administrative (2010 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.74 Bn | 192.75 Bn | 7.24 Bn | 1.75 Bn |
| 2 | Gilead Sciences | 179.96 Bn | 176.78 Bn | 6.22 Bn | 1.92 Bn |
| 3 | Vertex Pharmaceuticals | 131.20 Bn | 123.35 Bn | 2.84 Bn | 582.20 Mn |
| 4 | Regeneron Pharmaceuticals | 82.05 Bn | 74.05 Bn | 3.93 Bn | 662.10 Mn |
| 5 | Argenx Se | 60.28 Bn | 55.10 Bn | 1.37 Bn | -417.00 Mn |
| 6 | Moderna | 53.67 Bn | 48.54 Bn | 52.00 Mn | 216.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.08 Bn | 29.78 Bn | 992.69 Mn | 347.92 Mn |
| 8 | Biogen | 31.91 Bn | 30.62 Bn | 1.96 Bn | 709.70 Mn |
| 9 | Roivant Sciences | 29.22 Bn | 29.22 Bn | 1.16 Mn | 165.53 Mn |
| 10 | IGC Pharma | 27.58 Mn | 27.32 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 1.41 Mn |
| Jun 30, 2025 | 1.78 Mn |
| Mar 31, 2025 | 570,000.00 |
| Dec 31, 2024 | 1.13 Mn |
| Sep 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 1.67 Mn |
| Mar 31, 2024 | 1.49 Mn |
| Dec 31, 2023 | 2.23 Mn |
| Sep 30, 2023 | 1.40 Mn |
| Jun 30, 2023 | 1.65 Mn |
| Mar 31, 2023 | 3.61 Mn |
| Dec 31, 2022 | 1.57 Mn |
| Sep 30, 2022 | 1.86 Mn |
| Jun 30, 2022 | 1.55 Mn |
| Mar 31, 2022 | 5.34 Mn |
| Dec 31, 2021 | 2.07 Mn |
| Sep 30, 2021 | 4.11 Mn |
| Jun 30, 2021 | 1.78 Mn |
| Mar 31, 2021 | 2.48 Mn |
| Dec 31, 2020 | 2.19 Mn |